O1-20-2a Randomized Phase II Study to Assess Trastuzumab Beyond Progression in HER2-positive Advanced Gastric Cancer: WJOG7112G
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.017
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV